Repertoire Immune Medicines is seeking an immunology-focused pharmacology leader to shape and advance a portfolio of T cell-targeted therapies in oncology and autoimmune disease. Reporting to the SVP of Integrated Therapeutic Engineering and Development, this leader will shape development-stage research strategy and execution, advancing programs from discovery through IND-enabling studies. The role requires deep scientific expertise and decisive leadership to define mechanisms of action, establish PK/PD and efficacy relationships, and translate T cell engager and mRNA/LNP modalities into clinically actionable programs. The successful candidate will ensure integration across discovery, platform, and development functions and influence portfolio direction and execution. The role leads translational medicine strategy across clinical development programs, including biomarker and clinical pharmacology plans for target engagement, proof-of-mechanism, proof-of-biology, dose optimization, and patient selection. The position integrates emerging biological, pharmacological, biomarker, PK/PD, and clinical data into development recommendations, supports clinical study design and execution, contributes translational content to regulatory submissions, and builds collaborations with internal and external partners. Repertoire Immune Medicines is a clinical-stage biotechnology company developing immune-based therapies for cancer and autoimmune disease. Its proprietary DECODE platform maps interactions between T cell receptors and antigen targets. The company’s lead oncology program, RPTR-1-201, has initiated a Phase 1/2 clinical trial across multiple solid tumor indications.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree